Lower Risk of Heart Failure and Death in Patients Initiated on Sodium-Glucose Cotransporter-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL Study (Comparative Effectiveness of Cardiovascular Outcomes in New Users of Sodium-Glucose Cotransporter-2 Inhibitors).

Author: Kosiborod, Mikhail MD; Cavender, Matthew A. MD, MPH; Fu, Alex Z. PhD; Wilding, John P. MD, PhD; Khunti, Kamlesh MD, PhD; Holl, Reinhard W. MD, PhD; Norhammar, Anna MD; Birkeland, Kare I. MD, PhD; Jorgensen, Marit Eika MD, PhD; Thuresson, Marcus PhD; Arya, Niki MSc; Bodegard, Johan MD, PhD; Hammar, Niklas PhD; Fenici, Peter MD, PhD; on behalf of the CVD-REAL Investigators and Study Group

Page: 249-259

http://ift.tt/2tAq7Aq